Susan Hilt

The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

Susan W. Barnett, Shan Lu, I Srivastava et al. · Journal of Virology · 2001 · 218 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Indresh K. Srivastava, Leonidas Stamatatos, Elaine Kan et al. · Journal of Virology · 2003 · 150 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Evaluation of Envelope Vaccines Derived from the South African Subtype C Human Immunodeficiency Virus Type 1 TV1 Strain

Ying Lian, Indresh K. Srivastava, Raúl Gómez Román et al. · Journal of Virology · 2005 · 53 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates

Indresh K. Srivastava, Elaine Kan, Yide Sun et al. · Virology · 2007 · 39 citations

Life Sciences, Infectious Diseases, Microbiology +16

Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa

Carlo Zambonelli, Antu Dey, Susan Hilt et al. · PLoS ONE · 2016 · 31 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17